Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches.
Diamantopoulos PT, Viniou NA.
Front Oncol. 2021 Nov 17;11:722507. doi: 10.3389/fonc.2021.722507. eCollection 2021.
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao KT, Gotlib J, Deininger MMN, Oh ST, Cortes JE, Collins RH Jr, Winton EF, Parker DR, Lee H, Reister A, Schultz, Savage S, Stevens, Brockett C, Subbiah N, Press RD, Raess PW, Cascio M, Dunlap J, Chen Y, Degnin C, Maxson JE, Tognon CE, Macey T, Druker BJ, Tyner JW.
J Clin Oncol. 2020 Apr 1;38(10):1006-1018. doi: 10.1200/JCO.19.00895. Epub 2019 Dec 27.
Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
Patnaik MM, Lasho T.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):460-464. doi: 10.1182/hematology.2020000163.
Atypical Presentation of Chronic Myelogenous Leukemia.
Updyke KM, Morales-Lappot J, Lee T.
Cureus. 2017 May 26;9(5):e1280. doi: 10.7759/cureus.1280.
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Brümmendorf TH.
J Clin Oncol. 2018 Jan 20;36(3):231-237. doi: 10.1200/JCO.2017.74.7162. Epub 2017 Nov 1.
Systemic infection due to atypical mycobacteria in patients with chronic myelogenous leukemia.
Akiyama H, Maruyama T, Uetake T, Kawaguchi K, Sakamaki H, Onozawa Y.
Rev Infect Dis. 1991 Sep-Oct;13(5):815-8. doi: 10.1093/clinids/13.5.815.
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
Dao KT, Tyner JW, Gotlib J.
Curr Hematol Malig Rep. 2017 Oct;12(5):432-441. doi: 10.1007/s11899-017-0413-y.
Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
Sadigh S, Hasserjian RP, Hobbs G.
Curr Opin Hematol. 2020 Mar;27(2):122-127. doi: 10.1097/MOH.0000000000000565.
Myelodysplastic/myeloproliferative neoplasms.
Cazzola M, Malcovati L, Invernizzi R.
Hematology Am Soc Hematol Educ Program. 2011;2011:264-72. doi: 10.1182/asheducation-2011.1.264.
Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
Kantarjian HM, Kurzrock R, Talpaz M.
Hematol Oncol Clin North Am. 1990 Apr;4(2):389-404.
